Cargando…

Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma

Plasma concentration of apoA-I, apoA-II and apoA-II-unassociated apoA-I was analyzed in 314 Japanese subjects (177 males and 137 females), including one (male) homozygote and 37 (20 males and 17 females) heterozygotes of genetic CETP deficiency. ApoA-I unassociated with apoA-II markedly and linearly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kido, Toshimi, Kurata, Hideaki, Kondo, Kazuo, Itakura, Hiroshige, Okazaki, Mitsuyo, Urata, Takeyoshi, Yokoyama, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985746/ https://www.ncbi.nlm.nih.gov/pubmed/27526664 http://dx.doi.org/10.1038/srep31532

Ejemplares similares

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
por: Kido, Toshimi, et al.
Publicado: (2017)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

Cholesterol Determines and Limits rHDL Formation from Human Plasma Apolipoprotein A-II and Phospholipid Membranes
por: Bassett, G. Randall, et al.
Publicado: (2012)

Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
por: Koska, Juraj, et al.
Publicado: (2022)

The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
por: Kaneva, Anastasiya M., et al.
Publicado: (2015)

Importance of Apolipoprotein A-I and A-II Composition in HDL and Its Potential for Studying COVID-19 and SARS-CoV-2
por: Cho, Kyung-Hyun
Publicado: (2021)

Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations
por: Gomaraschi, Monica, et al.
Publicado: (2011)

Retardation of Aβ42 fibril formation by apolipoprotein A-I and recombinant HDL particles
por: Frankel, Rebecca, et al.
Publicado: (2023)

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ(1)-HDL, α-HDL, and triglyceride-rich lipoproteins
por: Chétiveaux, Maud, et al.
Publicado: (2020)

Human Serum Amyloid a Impaired Structural Stability of High-Density Lipoproteins (HDL) and Apolipoprotein (Apo) A-I and Exacerbated Glycation Susceptibility of ApoA-I and HDL
por: Cho, Kyung-Hyun
Publicado: (2022)

Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I
por: Hossain, Mohammad A, et al.
Publicado: (2012)

Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly
por: Patel, Hiren, et al.
Publicado: (2019)

The Association between Apolipoprotein A-II and Metabolic Syndrome in Korean Adults: A Comparison Study of Apolipoprotein A-I and Apolipoprotein B
por: Yi, Dong Won, et al.
Publicado: (2012)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Effect of urotensin II on apolipoprotein B(100) and apolipoprotein A-I expression in HepG2 cell line
por: Mohammadi, Abbas, et al.
Publicado: (2014)

Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma
por: Huang, Rong, et al.
Publicado: (2011)

Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I
por: De Souza, Juliana A, et al.
Publicado: (2010)

Sterically stabilized recombined HDL composed of modified apolipoprotein A-I for efficient targeting toward glioma cells
por: Li, Jin, et al.
Publicado: (2020)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
por: Bobin-Dubigeon, Christine, et al.
Publicado: (2022)

The Effects of Rope Training on Lymphocyte ABCA1 Expression, Plasma ApoA-I and HDL-c in Boy Adolescents
por: Ghorbanian, Bahloul, et al.
Publicado: (2013)

Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman Primates
por: Kushwaha, Rampratap S., et al.
Publicado: (2004)

Apolipoprotein A-I and Cancer
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2015)

On the Aggregation of Apolipoprotein A-I
por: Frankel, Rebecca, et al.
Publicado: (2022)

Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer
por: Mentese, Ahmet, et al.
Publicado: (2017)

Long-Term Alcohol Consumption Caused a Significant Decrease in Serum High-Density Lipoprotein (HDL)-Cholesterol and Apolipoprotein A-I with the Atherogenic Changes of HDL in Middle-Aged Korean Women
por: Cho, Kyung-Hyun, et al.
Publicado: (2022)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

Apolipoprotein A-I, A-II, and H mRNA and protein accumulation sites in the developing lung in late gestation
por: Côté, Mélissa, et al.
Publicado: (2011)

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
por: Millar, John S., et al.
Publicado: (2017)

Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes
por: Sobczak, Amélie I. S., et al.
Publicado: (2019)

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
por: Michael Gibson, C., et al.
Publicado: (2016)

Antitumor Activity of a Novel Quinoline Derivative, TAS‐103, with Inhibitory Effects on Topoisomerases I and II
por: Utsugi, Teruhiro, et al.
Publicado: (1997)

Comparison of Apolipoprotein (apoB/apoA-I) and Lipoprotein (Total Cholesterol/HDL) Ratio Determinants. Focus on Obesity, Diet and Alcohol Intake
por: Tognon, Gianluca, et al.
Publicado: (2012)

Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
por: Georgila, Konstantina, et al.
Publicado: (2019)

Identification and differential expression of serotransferrin and apolipoprotein A-I in the plasma of HIV-1 patients treated with first-line antiretroviral therapy
por: Barik, Sushanta Kumar, et al.
Publicado: (2020)

Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure
por: Yang, Mu, et al.
Publicado: (2018)

Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz, Godfrey S, et al.
Publicado: (2011)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Importance of Apolipoprotein A-I in Multiple Sclerosis
por: Gardner, Lidia A., et al.
Publicado: (2015)

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk
por: Orsi, Fernanda A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j7e78vhun177b2v9godjrg9441